Rani Therapeutics Holdings, Inc.
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
RANI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7530181004
- LEI:
- Country:
- United States of America
- Address:
- 2051 RINGWOOD AVENUE, 95131 SAN JOSE
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on developing orally administered biologics. The company has created the RaniPill® capsule, a proprietary and disruptive platform technology designed to convert injectable drugs, such as peptides, proteins, and antibodies, into oral pills. This technology aims to replace painful injections for patients with chronic diseases, potentially improving adherence and quality of life across a wide range of therapeutic areas. Rani's core business revolves around advancing its pipeline of oral biologic candidates through clinical development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Rani Therapeutics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Rani Therapeutics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Rani Therapeutics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
